How approval may impact treatment of allergy patients, otolaryngology practices
FDA Approves First Sublingual Allergy Immunotherapy Agents
Medications Oralair, Grastek, Ragwitek are designed to treat grass pollen-induced rhinitis, ragweed allergies
Intubation Risk Factors in Angioedema
What are the risk factors for progression and airway intervention of angioedema after initial evaluation?
Increasing RTP Levels Reduces Bleeding, Improves Surgical Field-of-View in ESS
What is the optimum amount of reverse Trendelenburg position to reduce bleeding without compromising surgical technique in endoscopic sinus surgery (ESS)?
SCIT Effective for Asthma, Allergic Rhinitis
How safe and effective is subcutaneous immunotherapy (SCIT), particularly single allergen regimens, for treating allergic rhinoconjunctivitis and asthma?
New Research Suggests Environmental Factors at Work in Allergenic Rhinitis and Food Allergies
Environmental pollutants, such as second-hand smoke, chlorine in pools, and pesticides are associated with greater risk for allergies, studies report
American Academy of Otolaryngic Allergy Focused on Advocacy, Patient Care
Organization offers education, research opportunities and funding
2013 CPT Code Changes May Impact Your Practice
New Current Procedural Terminology codes, including codes for reporting pediatric sleep studies and intraoperative neurophysiology monitoring, are now available.
Closing the Knowledge Gap: New food allergy guidelines provide clarity to some otolaryngologists
Another Option for Allergic Rhinitis?: Study examines long-term safety, efficacy of RF turbinoplasty
When patients with allergic rhinitis don’t respond to medical therapy, an otolaryngologist’s arsenal of treatment includes surgical options. Among these is radiofrequency (RF) turbinate reduction, also known as RF turbinate ablation or turbinoplasty, an office procedure that advocates say is cost-effective and minimally invasive, with fewer complications than other surgical remedies. Some otolaryngologists, however, are still hesitant to use this relatively new therapy.